|
Volumn 7, Issue 4, 2010, Pages 922-932
|
Antimycobacterial metabolites from Plectranthus: Royleanone derivatives against Mycobacterium tuberculosis strains
|
Author keywords
[No Author keywords available]
|
Indexed keywords
6,7 DEHYDROROYLEANONE;
6BETA,7ALPHA DIACETOXY 12 O ACETYLROYLEANONE(6BETA,7ALPHA) 11,14 DIOXOABIETA 8,12 DIENE 6,7,12 TRIYL TRIACETATE;
6BETA,7ALPHA DIHYDROXYROYLEANONE;
6BETA,7BETA DIACETOXYROYLEANONE(6BETA,7ALPHA) 12 HYDROXY 11,14 DIOXOABIETA 8,12 DIENE 6,7 DIYL DIACETATE;
7ALPHA ACETOXY 6ALPHA [(4 CHLOROBENZOYL)OXY] 12 O (4 CHLOROBENZOYL)ROYLEANONE(6BETA,7ALPHA) 7 (ACETYLOXY) 11,14 DIOXOABIETA 8,12 DIENE 6,12 DIYL BIS(4 CHLOROBENZOATE);
7ALPHA ACETOXY 6BETA (4 NITROBENZOYL)OXYROYLEANONE(6BETA,7ALPHA) 7 (ACETYLOXY) 12 HYDROXY 11,14 DIOXOABIETA 8,12 DIEN 12 YL 4 NITROBENZOATE;
7ALPHA ACETOXY 6BETA (PROPANOYLOXY) 12 O PROPANOYLROYLEANONE(6BETA,7ALPHA) 7 (ACETOXY) 11,14 DIOXOABIETA 8,12 DIENE 6,12 DIYL DIPROPANOATE;
7ALPHA ACETOXY 6BETA BENZOYLOXY 12 O BENZOYLROYLEANONE(6BETA,7ALPHA) 7 (ACETYLOXY) 11,14 DIOXOABIETA 8,12 DIENE 6,12 DIYL DIBENZOATE;
7ALPHA ACETOXY 6BETA BUTANOYLOXYROYLEANONE(6BETA,7ALPHA) 7 (ACETYLOXY) 12 HYDROXY 11,14 DIOXOABIETA 8,12 DIEN 6 YL BUTANOATE;
7ALPHA ACETOXY 6BETA HYDROXY 12 O (4 CHLOROBENZOYL)ROYLEANONE(6BETA,7ALPHA) 7 (ACETYLOXY) 6 HYDROXY 11,14 DIOXOABIETA 8,12 DIEN 12 YL 4 CHLOROBENZOATE;
7ALPHA ACETOXY 6BETA HYDROXY 12 O (4 METHOXYBENZOYL)ROYLEANONE(6BETA,7ALPHA) 7 (ACETYLOXY) 6 HYDROXY 11,14 DIOXOABIETA 8,12 DIEN 12 YL 4 METHOXYBENZOATE;
7ALPHA ACETOXY 6BETA HYDROXY 12 O (4 NITROBENZOYL)ROYLEANONE(6BETA,7ALPHA) 7 (ACETYLOXY) 6 HYDROXY 11,14 DIOXOABIETA 8,12 DIEN 12 YL 4 NITROBENZOATE;
7ALPHA ACETOXY 6BETA HYDROXYROYLEANONE;
7ALPHA ACETOXY 6BETA PROPANOYLOXYROYLEANONE(6BETA,7ALPHA) 7 (ACETLOXY) 12 HYDROXY 11,14 DIOXOABIETA 8,12 DIEN 6 YL PROPANOATE;
ANTIMYCOBACTERIAL AGENT;
DITERPENOID;
ENT 12BETA ACETOXYKAUR 16 EN 19 OIC ACID;
ENT 7BETA HYDROXY 15BETA,16BETA EPOXYKAURAN 19 OIC ACID;
ENT KAUR 15 EN 19 OIC ACID;
HORMINONE;
ISONIAZID;
QUINONE DERIVATIVE;
RHINOCEROTINOIC ACID;
RIFAMPICIN;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANTIBACTERIAL ACTIVITY;
ARTICLE;
CELL STRAIN 3T3;
CHEMICAL MODIFICATION;
CONTROLLED STUDY;
DRUG CYTOTOXICITY;
DRUG ISOLATION;
DRUG POTENCY;
DRUG SCREENING;
DRUG SELECTIVITY;
MINIMUM INHIBITORY CONCENTRATION;
MYCOBACTERIUM TUBERCULOSIS;
NONHUMAN;
NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;
PLECTRANTHUS;
PLECTRANTHUS GRANDIDENTATUS;
STRUCTURE ACTIVITY RELATION;
VERO CELL;
3T3 CELLS;
ANIMALS;
ANTI-BACTERIAL AGENTS;
CERCOPITHECUS AETHIOPS;
DITERPENES, ABIETANE;
DRUG RESISTANCE, MULTIPLE, BACTERIAL;
MICE;
MICROBIAL SENSITIVITY TESTS;
MYCOBACTERIUM TUBERCULOSIS;
PLECTRANTHUS;
VERO CELLS;
MYCOBACTERIUM TUBERCULOSIS;
PLECTRANTHUS;
|
EID: 77951197862
PISSN: 16121872
EISSN: 16121880
Source Type: Journal
DOI: 10.1002/cbdv.200900099 Document Type: Article |
Times cited : (50)
|
References (20)
|